Mycobacterium genavense in the Netherlands: an opportunistic pathogen in HIV and non-HIV immunocompromised patients. An observational study in 14 cases

Mycobacterium genavense is an opportunistic non-tuberculous mycobacterium previously mostly associated with HIV-infected patients with CD4 counts below 100/µL. In this retrospective observational study of medical charts we studied all Dutch patients in whom M. genavense was detected between January...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clinical microbiology and infection Ročník 19; číslo 5; s. 432 - 437
Hlavní autoři: Hoefsloot, W., van Ingen, J., Peters, E.J.G., Magis-Escurra, C., Dekhuijzen, P.N.R., Boeree, M.J., van Soolingen, D.
Médium: Journal Article
Jazyk:angličtina
Vydáno: Oxford, UK Elsevier Ltd 01.05.2013
Blackwell Publishing Ltd
Elsevier Limited
Témata:
ISSN:1198-743X, 1469-0691, 1469-0691
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Mycobacterium genavense is an opportunistic non-tuberculous mycobacterium previously mostly associated with HIV-infected patients with CD4 counts below 100/µL. In this retrospective observational study of medical charts we studied all Dutch patients in whom M. genavense was detected between January 2002 and January 2010. Of the 14 patients identified, 13 (93%) showed clinically relevant M. genavense disease. All patients with M. genavense disease were severely immunocompromised, including HIV-infected patients, solid organ transplant recipients, those with chronic steroid use in combination with other immune modulating drugs, recipients of chemotherapy for non-Hodgkin lymphoma, and those with immunodeficiency syndromes. Two patients had non-disseminated pulmonary M. genavense disease. Of the 12 patients treated, eight (75%) showed a favourable outcome. Four patients died in this study, three despite treatment for M. genavense disease. We conclude that M. genavense is a clinically relevant pathogen in severely immunocompromised patients that causes predominantly disseminated disease with serious morbidity and mortality. M. genavense is increasingly seen among non-HIV immunocompromised patients.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1198-743X
1469-0691
1469-0691
DOI:10.1111/j.1469-0691.2012.03817.x